Literature DB >> 15662135

Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations.

Radka Stoyanova1, Margie L Clapper, Alfonso Bellacosa, Elizabeth P Henske, Joseph R Testa, Eric A Ross, Anthony T Yeung, Emmanuelle Nicolas, Nicolaos Tsichlis, Yue-Sheng Li, W Marston Linehan, Sharon Howard, Kerry S Campbell, Andrew K Godwin, Bruce M Boman, James A Crowell, Levy Kopelovich, Alfred G Knudson.   

Abstract

BACKGROUND: The inherently complex signaling networks of tumors result from genetic and epigenetic alterations that occur during cancer initiation and progression.
METHODS: In an attempt to identify early molecular changes associated with dominantly inherited predisposition to "two-hit" renal tumors, the expression profiles of primary cultures of phenotypically normal renal epithelial cells from individuals bearing a germline mutation in either the von Hippel-Lindau (VHL) or the tuberous sclerosis complex (TSC) gene were compared to that of renal epithelial cells from control nonmutation carriers by microarray analysis.
RESULTS: Reliability of the microarray data from pooled samples was confirmed by real-time RT-PCR. Principal Component Analysis revealed substantial differences in the gene expression profiles of the renal epithelial cells from VHL and TSC mutation carriers. In several instances, the microarray data confirm our present knowledge of the cellular pathways affected by biallelic VHL and TSC mutations.
CONCLUSIONS: These findings demonstrate that heterozygosity for a mutant tumor suppressor gene may alter the expression profiles of phenotypically normal epithelial cells in a gene-specific manner. Detectable effects of "one-hit" represent early molecular changes in tumorigenesis that may serve as targets for chemopreventive intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662135     DOI: 10.4161/cbt.3.12.1459

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  12 in total

1.  One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis.

Authors:  Anthony T Yeung; Bhavinkumar B Patel; Xin-Ming Li; Steven H Seeholzer; Renata A Coudry; Harry S Cooper; Alfonso Bellacosa; Bruce M Boman; Tao Zhang; Samuel Litwin; Eric A Ross; Peggy Conrad; James A Crowell; Levy Kopelovich; Alfred Knudson
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

2.  Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma.

Authors:  Jinfei Xu; Yuwaraj Kadariya; Mitchell Cheung; Jianming Pei; Jacqueline Talarchek; Eleonora Sementino; Yinfei Tan; Craig W Menges; Kathy Q Cai; Samuel Litwin; Hongzhuang Peng; Jayashree Karar; Frank J Rauscher; Joseph R Testa
Journal:  Cancer Res       Date:  2014-06-13       Impact factor: 12.701

3.  Heritable one-hit events defining cancer prevention?

Authors:  Levy Kopelovich; Brittney Shea-Herbert
Journal:  Cell Cycle       Date:  2013-07-29       Impact factor: 4.534

4.  Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors.

Authors:  J Mathivanan; K Rohini; Mohan L Gope; B Anandh; Rajalakshmi Gope
Journal:  Mol Cell Biochem       Date:  2007-02-23       Impact factor: 3.396

5.  Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.

Authors:  Alfonso Bellacosa; Andrew K Godwin; Suraj Peri; Karthik Devarajan; Elena Caretti; Lisa Vanderveer; Betsy Bove; Carolyn Slater; Yan Zhou; Mary Daly; Sharon Howard; Kerry S Campbell; Emmanuelle Nicolas; Anthony T Yeung; Margie L Clapper; James A Crowell; Henry T Lynch; Eric Ross; Levy Kopelovich; Alfred G Knudson
Journal:  Cancer Prev Res (Phila)       Date:  2010-01

6.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

7.  A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.

Authors:  Brittney-Shea Herbert; Rebecca A Chanoux; Yunlong Liu; Peter H Baenziger; Chirayu P Goswami; Jeanette N McClintick; Howard J Edenberg; Robert E Pennington; Steven M Lipkin; Levy Kopelovich
Journal:  Oncotarget       Date:  2010-10

8.  APC +/- alters colonic fibroblast proteome in FAP.

Authors:  Bhavinkumar B Patel; Xin-Ming Li; Maketa P Dixon; Elena L Blagoi; Emmanuelle Nicolas; Steven H Seeholzer; David Cheng; Yin A He; Renata A Coudry; Sharon D Howard; Dawn M Riddle; Harry C Cooper; Bruce M Boman; Peggy Conrad; James A Crowell; Alfonso Bellacosa; Alfred Knudson; Anthony T Yeung; Levy Kopelovich
Journal:  Oncotarget       Date:  2011-03

Review 9.  The not-so-sweet side of sugar: Influence of the microenvironment on the processes that unleash cancer.

Authors:  Mam Y Mboge; Mina J Bissell
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-09-09       Impact factor: 6.633

10.  Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.

Authors:  Suraj Peri; Karthik Devarajan; Dong-Hua Yang; Alfred G Knudson; Siddharth Balachandran
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.